Modulation of LDL Oxidation by 7,8-Dihydroneopterin

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Free radical research

• Publication date

  2004-01-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1080/10715760310001623322PMID 15061649
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell-mediated reduction of protein and peptide hydroperoxides to reactive free radicals.

  2003cited by this paper
• Neopterin and 7,8-Dihydroneopterin Interfere With Low Density Lipoprotein Oxidation Mediated by Peroxynitrite and/or Copper

  2002cited by this paper
• Radical-scavenging and iron-chelating properties of carvedilol, an antihypertensive drug with antioxidative activity.

  2001cited by this paper
• Presence of aldehydic epitopes on a minor low-density lipoprotein fraction.

  1999cited by this paper
• Formation of oxygen radicals in solutions of 7,8-dihydroneopterin.

  1999cited by this paper
• The Oxidation of Lipoproteins by Monocytes-Macrophages

  1999cited by this paper
• Ceruloplasmin copper induces oxidant damage by a redox process utilizing cell-derived superoxide as reductant.

  1998cited by this paper
• Cell-mediated oxidation of LDL: comparison of different cell types of the atherosclerotic lesion.

  1998cited by this paper
• Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis.

  1998cited by this paper
• LDL- is a lipid hydroperoxide-enriched circulating lipoprotein.

  1997influential reference
• Low Density Lipoprotein Oxidation and Its Pathobiological Significance*

  1997cited by this paper
• The Role of Oxidized LDL in Atherogenesis: Immunological Response and Anti‐phospholipid Antibodies

  1997cited by this paper
• Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells.

  1996cited by this paper
• Collagenous macrophage scavenger receptors

  1996cited by this paper
• Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics.

  1995cited by this paper
• 7,8 Dihydroneopterin inhibits low density lipoprotein oxidation in vitro. Evidence that this macrophage secreted pteridine is an anti-oxidant.

  1995cited by this paper
• Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease.

  1995cited by this paper
• Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus

  1995cited by this paper
• Neopterin and prognosis in patients with adenocarcinoma of the colon.

  1993cited by this paper
• The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

  1992cited by this paper
• Induction of ceruloplasmin gene expression in rat lung during inflammation and hyperoxia.

  1991cited by this paper
• POSTTRANSPLANT NEOPTERIN EXCRETION IN RENAL ALLOGRAFT RECIPIENTS—A RELIABLE DIAGNOSTIC AID FOR ACUTE REJECTION AND A PREDICTIVE MARKER OF LONG‐TERM GRAFT SURVIVAL

  1991cited by this paper
• Human ceruloplasmin. Tissue-specific expression of transcripts produced by alternative splicing.

  1990cited by this paper
• Biochemical, structural, and functional properties of oxidized low-density lipoprotein.

  1990cited by this paper
• The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

  1990cited by this paper
• Detection of new epitopes formed upon oxidation of low-density lipoprotein, lipoprotein (a) and very-low-density lipoprotein. Use of an antiserum against 4-hydroxynonenal-modified low-density lipoprotein.

  1990cited by this paper
• A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent.

  1989cited by this paper
• Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application.

  1989cited by this paper
• Superoxide anion participation in human monocyte-mediated oxidation of low-density lipoprotein and conversion of low-density lipoprotein to a cytotoxin.

  1989cited by this paper
• Neopterin as a marker for activated cell-mediated immunity: application in HIV infection.

  1988cited by this paper
• Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal.

  1986cited by this paper
• Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma

  1984cited by this paper

• Synthesis, Tautomerism, and Antiradical Activity of Novel Pteridinetrione Derivatives

  2018cites this paper
• Lysosomal oxidation of Low Density Lipoproteins

  2017cites this paper
• Cytokines in atherosclerosis: an intricate balance

  2016cites this paper
• Interferons as Essential Modulators of Atherosclerosis.

  2015cites this paper
• Antioxidants, inflammation and cardiovascular disease.

  2014cites this paper
• Elevated Serum Gamma-Glutamyltransferase (GGT) Activity and the Development of Chronic Kidney Disease (CKD) in Cigarette Smokers

  2013cites this paper
• Mechanisms of 7,8-dihydroneopterin protection of macrophages from cytotoxicity

  2013cites this paper
• Oxidant Production, oxLDL Uptake, and CD36 Levels in Human Monocyte–Derived Macrophages Are Downregulated by the Macrophage-Generated Antioxidant 7,8-Dihydroneopterin

  2010cites this paper
• Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8‐dihydroneopterin synthesis

  2008cites this paper
• Macrophage mediated protein hydroperoxide formation and lipid oxidation in low density lipoprotein are inhibited by the inflammation marker 7,8-dihydroneopterin.

  2008cites this paper
• Inflammatory sites as a source of plasma neopterin: measurement of high levels of neopterin and markers of oxidative stress in pus drained from human abscesses.

  2008cites this paper
• A model of complex plaque formation: 7,8-Dihydroneopterin protects human monocyte-derived macrophages from oxidised low density lipoprotein-induced death

  2008cites this paper
• 7,8-Dihydroneopterin-mediated protection of low density lipoprotein, but not human macrophages, from oxidative stress

  2006cites this paper
• Evaluation of serum neopterin, high-sensitivity C-reactive protein and thiobarbituric acid reactive substances in Egyptian patients with acute coronary syndromes.

  2005cites this paper
• Gamma interferon: a central mediator in atherosclerosis

  2005cites this paper
• Nutrition and metabolism Intentional weight loss, blood lipids and coronary morbidity and mortality Review: Intentional weight loss, blood lipids and coronary morbidity and mortality (pp. 5–9)

  2005cites this paper
• Interference of 7,8-dihydroneopterin with peroxynitrite-mediated reactions.

  2004cites this paper